marketed in the US by J&J and in Europe by Merck of Whitehouse Station, New Jersey, following its acquisition of Kenilworth, New Jersey–based Schering-Plough. It is also pitted against a more ...

Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare diseases drugmaker soaring. One of SpringWorks’ drugs, Ogsiveo, is ...

RAHWAY, N.J. (AP) — RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Tuesday reported fourth-quarter net income of $3.74 billion. On a per-share basis, the Rahway, New Jersey-based company said it had ...

New Jersey, company. For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda ...

Bojangles, the beloved Southern-based fried chicken chain, is gearing up to open in New Jersey. The 2,895-square-foot Monmouth County restaurant will feature a drive-thru. No opening date or ...

Dr David Whitehouse said the measure could be taken against a space rock the size of a football pitch which is being monitored by the European Space Agency (ESA) and could strike the planet in a ...

Jalen Hurts and the Philadelphia Eagles are Super Bowl champions! Hurts was named MVP of Super Bowl LIX after throwing for two touchdowns and running for another. Eagles fans, it's time to celebrate.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

COLLEGE STATION, Texas (KBTX) - The City of College Station and 11 members of the College Station Police Department are named as defendants in a new federal lawsuit connected to the execution of a ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...